← Leaderboards
Nikki Cheng
Vanderbilt University
$4,462,144
Attributed
$5,524,340
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $496K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,524,340 · 5
By mechanism
R01$4,199,885 · 1
R00$732,059 · 1
K99$297,696 · 1
R03$153,000 · 1
F32$141,700 · 1
Top collaborators
- Fariba Behbod6 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Pierre P Massion$18,568,000
- Lynn M Matrisian$19,522,211
- Robert J Coffey$53,530,293
- Katarzyna Anna Rejniak$3,592,414
- Anita Mahadevan-Jansen$15,180,169
Others in their field
Top investigators on “Tumor Progression”
- David Heimbrook · Leidos Biomedical Research, Inc.$115,077,246
- Timothy J Eberlein · Washington University$82,758,282
- Eric S Lander · Whitehead Institute For Biomedical Res$71,530,862
- C Kent Osborne · Baylor College Of Medicine$50,727,195
- Walter John Curran · Thomas Jefferson University$47,825,103
- Alan F Horwitz · University Of Virginia Charlottesville$42,280,666
Research focus
Tumor ProgressionCellsCcl2 GeneMacrophageMediatingMouse ModelMolecularMalignant Breast NeoplasmBaseCarcinomaSignal TransductionChemokineCell MotilityBreast Cancer CellBiochemicalTumorIn VivoMammary NeoplasmsMammary GlandDiagnosisFibroblastsAutocrineBreastMalignant Neoplasms
Grant awards (22)
Progression of DCIS to Invasive Breast Cancer through CCR2 Chemokine Signaling$345,567
R01 · FY2024 · CA · contact PI
Progression of DCIS to Invasive Breast Cancer through CCR2 Chemokine Signaling$385,659
R01 · FY2023 · CA · contact PI
Progression of DCIS to Invasive Breast Cancer through CCR2 Chemokine Signaling$471,581
R01 · FY2022 · CA · contact PI
Progression of DCIS to Invasive Breast Cancer through CCR2 Chemokine Signaling$453,140
R01 · FY2021 · CA · contact PI
Progression of DCIS to Invasive Breast Cancer through CCR2 Chemokine Signaling$419,545
R01 · FY2020 · CA · contact PI
Role of tumoral derived CCL2 in skeletal muscle wasting in breast cancer$76,500
R03 · FY2020 · CA · contact PI
Role of tumoral derived CCL2 in skeletal muscle wasting in breast cancer$76,500
R03 · FY2019 · CA · contact PI
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$413,485
R01 · FY2017 · CA · contact PI
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$412,331
R01 · FY2016 · CA · contact PI
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$66,378
R01 · FY2016 · CA · contact PI
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$414,124
R01 · FY2015 · CA · contact PI
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$404,660
R01 · FY2014 · CA · contact PI
Progression of DCIS to invasive breast cancer through CCR2 chemokine signaling$413,415
R01 · FY2013 · CA · contact PI
Functions of chemokine and TGF-B signaling in the breast cancer microenvironment$241,530
R00 · FY2012 · CA · contact PI
Functions of chemokine and TGF-B signaling in the breast cancer microenvironment$241,529
R00 · FY2011 · CA · contact PI
Functions of chemokine and TGF-B signaling in the breast cancer microenvironment$249,000
R00 · FY2010 · CA · contact PI
Functions of chemokine and TGF-B signaling in the breast cancer microenvironment$123,170
K99 · FY2009 · CA · contact PI
Functions of chemokine and TGF-B signaling in the breast cancer microenvironment$54,000
K99 · FY2009 · CA · contact PI
Functions of chemokine and TGF-B signaling in the breast cancer microenvironment$120,526
K99 · FY2008 · CA · contact PI
Stromal TGFbeta in tumor progression$50,428
F32 · FY2006 · CA · contact PI
Stromal TGFbeta in tumor progression$48,296
F32 · FY2005 · CA
Stromal TGFbeta in tumor progression$42,976
F32 · FY2004 · CA